Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial

Item Type:Article
Title:Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial
Creators Name:Mähler, A. and Steiniger, J. and Bock, M. and Klug, L. and Parreidt, N. and Lorenz, M. and Zimmermann, B.F. and Krannich, A. and Paul, F. and Boschmann, M.
Abstract:BACKGROUND: Muscle weakness and fatigue are common symptoms in multiple sclerosis (MS). Green tea catechins such as (-)epigallocatechin-3-gallate (EGCG) are known to improve energy metabolism at rest and during exercise. OBJECTIVE: We tested the hypothesis that EGCG improves energy metabolism and substrate utilization in patients with MS. DESIGN: Eighteen patients (8 men) with relapsing-remitting MS (expanded disability status scale score <4.5, all receiving glatiramer acetate) participated in this randomized, double-blind, placebo-controlled, crossover trial at a clinical research center. All patients received EGCG (600 mg/d) and placebo over 12 wk (4-wk washout in between). After each intervention, fasting and postprandial energy expenditure (EE), as well as fat oxidation (FAOx) and carbohydrate oxidation (CHOx) rates, were measured either at rest or during 40 min of exercise (0.5 W/kg). At rest, blood samples and microdialysates from adipose tissue and skeletal muscle were also taken. RESULTS: At rest, postprandial EE and CHOx, as well as adipose tissue perfusion and glucose supply, were significantly lower in men but higher in women receiving EGCG compared with placebo. During exercise, postprandial EE was lower after EGCG than after placebo, indicating an increased working efficiency (men > women). After placebo, exercise EE was mainly fueled by FAOx in both men and women. After EGCG, there was a shift to a higher and more stable CHOx during exercise in men but not in women. CONCLUSIONS: Our data indicate that EGCG given to patients with MS over 12 wk improves muscle metabolism during moderate exercise to a greater extent in men than in women, possibly because of sex-specific effects on autonomic and endocrine control. This trial was registered at clinicaltrials.gov as NCT01417312.
Keywords:Energy Metabolism, Epigallocatechin-3-Gallate, Multiple Sclerosis, Sex Difference, Calorimetry, Microdialysis
Source:American Journal of Clinical Nutrition
ISSN:0002-9165
Publisher:American Society for Nutrition (U.S.A.)
Volume:101
Number:3
Page Range:487-495
Date:March 2015
Official Publication:https://doi.org/10.3945/ajcn.113.075309
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library